Institut Gustave Roussy (IGR)

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Liver and biliary tract cancer2 trials
• Lung cancer2 trials
• Bladder cancer1 trial
• Childhood cancers1 trial
• Head and neck cancer1 trial
• Thyroid cancer1 trial

Phase

• Phase 1/22 trials
• Phase 11 trial

Status

• Recruiting3 trials
• Completed1 trial
• Suspended1 trial

Lead sponsor

• Alentis Therapeutics AG1 trial
• Brenus Pharma1 trial
• Centre Francois Baclesse1 trial
• Eli Lilly and Company1 trial
• University Hospital, Angers1 trial

Running trials

• Recruiting

  Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

  NCT06990659· University Hospital, Angers· Source

  Contact: Paul BEUNON, Dr

• Recruiting

  A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  NCT07169734· Phase 1/2· Alentis Therapeutics AG· Source

  Contact: Principal Investigator

• Recruiting

  First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

  NCT06934538· Phase 1/2· Brenus Pharma· Source

  Contact: Antoine Hollebecque, M.D

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• Liver and biliary tract cancer2 recruiting
• Bladder cancer1 recruiting
• Lung cancer1 recruiting

Closed trials

• Completed

  A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

  NCT05241834· Phase 1· Eli Lilly and Company· Source